Source: Hepatitis monthly. Unidade: FM
Subjects: INIBIDORES DE ENZIMAS, SELEÇÃO DE PACIENTES, CARCINOMA HEPATOCELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEATHERS, James S. e CARRILHO, Flair. PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings. Hepatitis monthly, v. 18, n. 10, 2018Tradução . . Disponível em: https://doi.org/10.5812/hepatmon.82345. Acesso em: 25 set. 2024.APA
Leathers, J. S., & Carrilho, F. (2018). PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings. Hepatitis monthly, 18( 10). doi:10.5812/hepatmon.82345NLM
Leathers JS, Carrilho F. PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings [Internet]. Hepatitis monthly. 2018 ; 18( 10):[citado 2024 set. 25 ] Available from: https://doi.org/10.5812/hepatmon.82345Vancouver
Leathers JS, Carrilho F. PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings [Internet]. Hepatitis monthly. 2018 ; 18( 10):[citado 2024 set. 25 ] Available from: https://doi.org/10.5812/hepatmon.82345